Concepedia

Hugo Vigerelli

HV

Statistics

Publications

11

Citations

228

H-Index

11

Active since

2014

Affiliations

Instituto Butantan(Current)

Universidade de São Paulo

Universidade São Francisco

Hugo Vigerelli is an author at Instituto Butantan specializing in pharmacology, infectious diseases, and venom biology.

Publications per year

2014–2023

11

Publications

11

Bufotenine is able to block rabies virus infection in BHK-21 cells

Hugo Vigerelli, Juliana Mozer Sciani, Carlos Jared et al. · The Journal of venomous animals and toxins including tropical diseases · 2014 · 46 citations · Full text

Medicine, Infectious Diseases, Pharmacology +6

Synergic effects between ocellatin-F1 and bufotenine on the inhibition of BHK-21 cellular infection by the rabies virus

Rene dos Santos Cunha Neto, Hugo Vigerelli, Carlos Jared et al. · The Journal of venomous animals and toxins including tropical diseases · 2015 · 29 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +15

A new class of antimicrobial molecules derived from kefir, effective against Pseudomonas aeruginosa and methicillin resistant Staphylococcus aureus (MRSA) strains

Vaniky Duarte Marques, Márcia Regina Franzolin, Sabri Saeed Sanabani et al. · Scientific Reports · 2020 · 24 citations · Full text

Life Sciences, Food Science, Microbiology +17

Biological Effects and Biodistribution of Bufotenine on Mice

Hugo Vigerelli, Juliana Mozer Sciani, Maria Andrea Camarano Eula et al. · BioMed Research International · 2018 · 21 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients

Rodrigo Pinheiro Araldi, Benedito C. Prezoto, Vivian Fonseca Gonzaga et al. · Biomedicine & Pharmacotherapy · 2022 · 21 citations · Full text

Dentistry, Immunology, Cell Therapy +7

1–5 of 11